Adjuvant therapy of malignant melanoma
- 1 October 2002
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 44 (1) , 81-102
- https://doi.org/10.1016/s1040-8428(02)00014-8
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Adjuvant trial in melanoma patients comparing rIFN-α to rIFN-γ to Iscador to a control group after curative resection of high risk primary (≥3 MM) or regional lymphnode metastasis (EORTC 18871)European Journal Of Cancer, 1999
- A randomized controlled trial of prophylactic isolated cytotoxic perfusion for poor-prognosis primary melanoma of the lower limbEuropean Journal of Surgical Oncology, 1997
- Thirty-five years of isolated limb perfusion for melanoma: Indications and resultsBritish Journal of Surgery, 1996
- Randomized Trial of Adjuvant Human Interferon Gamma Versus Observation in High-Risk Cutaneous Melanoma: a Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1995
- Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC protocol 18781)European Journal Of Cancer, 1993
- Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremitiesWorld Journal of Surgery, 1992
- Phase II study of recombinant leukocyte a interferon (rIFN-αA) in disseminated malignant melanomaCancer, 1984
- A Randomized Trial of Adjuvant Chemotherapy and Immunotherapy in Cutaneous MelanomaNew England Journal of Medicine, 1982
- Immunotherapy of Malignant MelanomaNew England Journal of Medicine, 1980
- BCG lmmunotherapy of Malignant MelanomaAnnals of Surgery, 1974